<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <channel>
    <title>Opinion Health - Latest Health News</title>
    <link>http://opinionhealth.co.uk/</link>
    <pubDate>Fri, 30 Jul 2010 07:41:06 GMT</pubDate>
    <description>A summary of the latest news on healthcare, as reported by the UK and International media</description>
    <item>
      <title>Challenge pregnant women to manage their weight, NICE says</title>
      <link>http://opinionhealth.co.uk/r/5968</link>
      <description>Myths about pregnancy and weight&#8212;such as that pregnant women need to &quot;eat for two&quot;&#8212;need to be challenged by GPs, midwives, and other healthcare workers, says new guidance from the UK National Institute for Health and Clinical Excellence (NICE).</description>
      <pubDate>Fri, 30 Jul 2010 07:41:06 GMT</pubDate>
      <guid>http://opinionhealth.co.uk/r/5461</guid>
      <author>BMJ</author>
    </item>
    <item>
      <title>Link between western diet and ADHD</title>
      <link>http://opinionhealth.co.uk/r/5967</link>
      <description>A new study from Perth's Telethon Institute for Child Health Research shows an association between ADHD and a 'Western-style' diet in adolescents.</description>
      <pubDate>Fri, 30 Jul 2010 07:40:39 GMT</pubDate>
      <guid>http://opinionhealth.co.uk/r/5460</guid>
    </item>
    <item>
      <title>Pregnancy-related diabetes likely to recur: study</title>
      <link>http://opinionhealth.co.uk/r/5966</link>
      <description>Pregnant women with a history of pregnancy-related diabetes, also called gestational diabetes, have a good chance of developing the condition again, suggests a large new study.</description>
      <pubDate>Fri, 30 Jul 2010 07:40:23 GMT</pubDate>
      <guid>http://opinionhealth.co.uk/r/5459</guid>
      <author>Reuters</author>
    </item>
    <item>
      <title>AstraZeneca doubles share buy-back plan</title>
      <link>http://opinionhealth.co.uk/r/5965</link>
      <description>AstraZeneca has upgraded earnings forecasts following strong US expert endorsement of its new drug Brilinta, as it pledged increased share buy-backs and unveiled strong second-quarter results.</description>
      <pubDate>Fri, 30 Jul 2010 07:40:01 GMT</pubDate>
      <guid>http://opinionhealth.co.uk/r/5458</guid>
    </item>
    <item>
      <title>Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis</title>
      <link>http://opinionhealth.co.uk/r/5964</link>
      <description>Objective - To investigate whether calcium supplements increase the risk of cardiovascular events.</description>
      <pubDate>Fri, 30 Jul 2010 07:39:46 GMT</pubDate>
      <guid>http://opinionhealth.co.uk/r/5457</guid>
      <author>BMJ</author>
    </item>
    <item>
      <title>Popular diabetes drugs associated with fractures in type 2 diabetic patients</title>
      <link>http://opinionhealth.co.uk/r/5963</link>
      <description>Postmenopausal women with diabetes taking thiazolidinediones (TZDS), including rosiglitazone and pioglitazone, may be at increased risk for fractures according to a new study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology &amp; Metabolism (JCEM).</description>
      <pubDate>Fri, 30 Jul 2010 07:39:30 GMT</pubDate>
      <guid>http://opinionhealth.co.uk/r/5456</guid>
    </item>
    <item>
      <title>Strong quarter for AstraZeneca as FDA panel backs Brilinta </title>
      <link>http://opinionhealth.co.uk/r/5961</link>
      <description>AstraZeneca shares are on the rise this morning after the firm posted a strong set of financials for the second quarter and celebrated a recommendation for approval from US advisory panel for its bloodthinner Brilinta.</description>
      <pubDate>Fri, 30 Jul 2010 07:39:05 GMT</pubDate>
      <guid>http://opinionhealth.co.uk/r/5455</guid>
    </item>
    <item>
      <title>Solid results at Sanofi, plays down Genzyme bid </title>
      <link>http://opinionhealth.co.uk/r/5959</link>
      <description>Sanofi-Aventis has posted a solid set of figures for the second quarter this morning, but has lowered its full-year earnings forecast due to the introduction last week of generic Lovenox in the USA.</description>
      <pubDate>Fri, 30 Jul 2010 07:38:44 GMT</pubDate>
      <guid>http://opinionhealth.co.uk/r/5454</guid>
    </item>
    <item>
      <title>Bayer pharma earnings fall as R&amp;D spend climbs </title>
      <link>http://opinionhealth.co.uk/r/5958</link>
      <description>Bayer has posted a 1.3% dip in net income for the second quarter to 525 million euros this morning, but the Leverkusen-based firm&#8217;s turnover climbed 14.6% to 9.18 billion euros.</description>
      <pubDate>Fri, 30 Jul 2010 07:38:21 GMT</pubDate>
      <guid>http://opinionhealth.co.uk/r/5453</guid>
    </item>
    <item>
      <title>Pfizer launches online men's health clinic</title>
      <link>http://opinionhealth.co.uk/r/5957</link>
      <description>Pfizer has launched ManMOT (Monday Opportunity to Talk), an online health clinic providing men in the UK with confidential access to a GP, every Monday from 6pm to 11pm.</description>
      <pubDate>Fri, 30 Jul 2010 07:37:59 GMT</pubDate>
      <guid>http://opinionhealth.co.uk/r/5452</guid>
      <author>PMLive</author>
    </item>
    <item>
      <title>Celgene profit up on Revlimid sales</title>
      <link>http://opinionhealth.co.uk/r/5956</link>
      <description>Celgene has reported a jump in second-quarter profits and has increased its earnings forecast for the full year, due mainly to strong sales of Revlimid (lenalidomide), the multiple myeloma drug that is derived from thalidomide.</description>
      <pubDate>Fri, 30 Jul 2010 07:37:46 GMT</pubDate>
      <guid>http://opinionhealth.co.uk/r/5451</guid>
      <author>PMLive</author>
    </item>
    <item>
      <title>Sleep disorder may help predict Parkinson's decades earlier</title>
      <link>http://opinionhealth.co.uk/r/5955</link>
      <description>A certain type of sleep disorder may be an early warning of Parkinson's disease and other neurological disorders, new research confirms.</description>
      <pubDate>Thu, 29 Jul 2010 07:48:47 GMT</pubDate>
      <guid>http://opinionhealth.co.uk/r/5450</guid>
      <author>HealthScout</author>
    </item>
    <item>
      <title>Sensor implant monitors blood sugar</title>
      <link>http://opinionhealth.co.uk/r/5954</link>
      <description>An implantable sensor that continuously monitors glucose levels has worked for more than a year in a pig, raising hopes for use in human diabetics, researchers report.</description>
      <pubDate>Thu, 29 Jul 2010 07:48:31 GMT</pubDate>
      <guid>http://opinionhealth.co.uk/r/5449</guid>
      <author>CBC</author>
    </item>
    <item>
      <title>Sipuleucel-T immunotherapy for castration-resistant prostate cancer</title>
      <link>http://opinionhealth.co.uk/r/5952</link>
      <description>Background - Sipuleucel-T, an autologous active cellular immunotherapy, has shown evidence of efficacy in reducing the risk of death among men with metastatic castration-resistant prostate cancer.</description>
      <pubDate>Thu, 29 Jul 2010 07:48:13 GMT</pubDate>
      <guid>http://opinionhealth.co.uk/r/5448</guid>
      <author>New England Journal of Medicine</author>
    </item>
    <item>
      <title>Pitt team says one molecule, many more insulin-producing cells to treat diabetes</title>
      <link>http://opinionhealth.co.uk/r/5951</link>
      <description>With a single stimulatory molecule, human insulin-producing beta cell replication can be sustained for at least four weeks in a mouse model of diabetes, according to researchers at the University of Pittsburgh School of Medicine in Diabetes, a journal of the American Diabetes Association.</description>
      <pubDate>Thu, 29 Jul 2010 07:47:51 GMT</pubDate>
      <guid>http://opinionhealth.co.uk/r/5447</guid>
    </item>
  </channel>
</rss>
